16.09.2013 14:00:00

Acquisitions, Product and Services Launches, Merger Agreement Updates and Monthly Sales Results - Research Report on Walgreen, Cardinal Health, Sears, Saks, and Rite Aid

NEW YORK, September 16, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Investors' Reports announced new research reports highlighting Walgreen Co. (NYSE: WAG), Cardinal Health, Inc. (NYSE: CAH), Sears Holdings Corporation (NASDAQ: SHLD), Saks Incorporated (NYSE: SKS), and Rite Aid Corp. (NYSE: RAD). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Walgreen Co. Research Report

On September 10, 2013, Walgreen Co. (Walgreen) announced that it has entered into a definitive agreement with Kerr Drug, a privately held regional pharmacy chain in North Carolina. Under the agreement, Walgreen will acquire certain assets of Kerr Drug's retail drugstores and specialty pharmacy business. "The Kerr Drug retail drugstores and specialty pharmacy business are an exceptional addition to the Walgreens family of companies," said Walgreens President and CEO Greg Wasson. "We are closely aligned on the important task of expanding the health care role that community pharmacists can have with their patients, and we share the common goal of stepping out of the traditional drugstore format to create a new experience for our customers." The Full Research Report on Walgreen Co. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-12/WAG]

--

Cardinal Health, Inc. Research Report

On September 3, 2013, Cardinal Health Inc. (Cardinal Health) announced that it has recently launched a customizable medicare Enrollment Toolkit to help retail pharmacy customers educate the rapidly growing Medicare-eligible population about coverage options. Myles Hoover, Vice President of Marketing and Customer Solutions for Cardinal Health commented, "This toolkit equips retail pharmacists - who are often their community's most accessible healthcare resource -- with the materials they need to let patients know about the Medicare open enrollment period and to reinforce that they can help patients navigate the system and better understand their coverage options." The Full Research Report on Cardinal Health, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-12/CAH]

--

Sears Holdings Corporation Research Report

On September 9, 2013, Sears Holdings Corp.'s (Sears) wholly owned subsidiary, Kmart, announced the launch of check cashing service for Shop Your Way members and customers at store locations nationwide. "With the addition of check cashing to our Kmart financial services portfolio, our Shop Your Way members now have the convenience of cashing checks where they shop, saving them time and money," said Jai Holtz, Vice President, Financial Services, Sears Holdings. "Along with Kmart's other financial services offerings, including Layaway, walk-in bill pay, money transfer, money orders, ATMs and prepaid debit cards and reloads, we are providing one-stop shopping for our members' needs." The Full Research Report on Sears Holdings Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-12/SHLD]

--

Saks Incorporated Research Report

On September 10, 2013, Saks Inc. (Saks) provided an update regarding its "go-shop" period related to its merger agreement with Hudson's Bay Company (HBC). According to the Company, the merger agreement was entered into on July 28, 2013 and contained a 40-day "go-shop" period during which Saks was permitted to solicit alternative proposals from third parties. The Company informed that the "go-shop" period expired on September 6, 2013, and Saks is now subject to customary "no-shop" provisions which are outlined in the merger agreement. The planned transaction has been approved by each Company's board of directors and is expected to close before the end of the calendar year 2013. The Full Research Report on Saks Incorporated - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-12/SKS]

--

Rite Aid Corp. Research Report

On September 5, 2013, Rite Aid Corp. (Rite Aid) reported its sales for August 2013. The Company reported same store sales growth of 1.1% YoY, pharmacy same store sales increased 2.5% YoY, while front-end same store sales declined 1.7% YoY. For the month, the Company reported total drugstore sales growth of 1.1% YoY to $2.4 billion. Further, for the 13-week period ended August 31, 2013, same store sales increased 1.0% YoY, Pharmacy same store sales grew 1.7% YoY, while front-end same store sales declined by 0.3% YoY. The Company's total drugstore sales for the 13 weeks ended August 31, 2013, grew 0.7% with total sales of c.$6.3 billion. The Full Research Report on Rite Aid Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-12/RAD]

----

EDITOR NOTES:

  • This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  • Information in this release is fact checked and produced on a best efforts basis and reviewed by an analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  • This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  • For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

  • COMPLIANCE PROCEDURE

    Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

    NOT FINANCIAL ADVICE

    Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

    NO WARRANTY OR LIABILITY ASSUMED

    Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

    InvestorsReports.com


    SOURCE Investors' Reports

    Nachrichten zu Rite Aid Corp.mehr Nachrichten

    Keine Nachrichten verfügbar.

    Analysen zu Rite Aid Corp.mehr Analysen

    Eintrag hinzufügen
    Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
    Es ist ein Fehler aufgetreten!

    Aktien in diesem Artikel

    Cardinal Health Inc. 115,75 -0,04% Cardinal Health Inc.